Filing Details
- Accession Number:
- 0001104659-25-025236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 21:16:52
- Reporting Period:
- 2025-03-14
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 21:16:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | Pharmaceutical Preparations (2834) | 462159271 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1774702 | Yann Mazabraud | 222 Berkeley Street, 12Th Floor Boston MA 02116 | Evp, Head Of International | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-14 | 75,000 | $22.28 | 115,370 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-14 | 19,197 | $50.79 | 96,173 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-14 | 55,803 | $51.72 | 40,370 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2025-03-14 | 75,000 | $0.00 | 75,000 | $22.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2030-10-04 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.
- The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $50.31 to $51.26 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $51.31 to $52.04 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The options are fully vested.
Billionaire Hedge Funds
